Today we get to hear about what experts in pharmaceutical technologies are doing in nanotechnology. We chat about the difference between lipophilic delivery and drug delivery. Victor Francis from DIVERSA gives us a really solid breakdown of the differences and what DIVERSA does with different types of drugs and their work with companies in the early stages of drug discovery.
DIVERSA is going to be one of our Innovation AveNEW companies at SLAS2022 in Boston, MA, USA in February 2022 and we are excited to see this start up in person!
DIVERSA was born as a biotechnology spin-off from the Nano-Oncology and Translational Therapeutics Unit of the Santiago de Compostela Health Research Institute (IDIS) and the Galician Health Service (SERGAS).
Want to reach out to Victor and learn more about their kits? Contact him here.